Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
August 26, 2021
In this episode of the new series Lagos to Mombasa, Abebe Aemro Selassie of the IMF and Charlie Robertson of Renaissance Capital join Gyude Moore to discuss how to increase investment in transportation, power, water, health, and education infrastructure to spur economic growth in African countr...
Blog Post
August 12, 2021
This first episode of the new Africa-centered podcast series Lagos to Mombasa examines how African governments can shape their responses to the pandemic and prepare for the future. Patrick Tippoo of Biovac and the African Vaccine Manufacturing Initiative and Prashant Yadav from CGD join Gyude M...
Blog Post
August 05, 2021
Next Thursday CGD will launch the new podcast series Lagos to Mombasa: The Trans-Africa Podcast from CGD. The series will focus on policies, problems, and promise across Africa. Join Gyude Moore every two weeks as he speaks to researchers and practitioners about some of the biggest development ...
Blog Post
July 19, 2021
The UK government is removing almost all COVID-19 restrictions from England in what the Prime Minister has as “Freedom Day”, but unfettered freedom does not exist. COVID is not going away any time soon. It’s time to prioritize transparency, consultation and long-term solutions. Everyone wa...
Blog Post
June 30, 2021
The US International Development Finance Corporation (DFC) is the $60 billion agency that’s supposed to catalyze investment to capital-starved countries, bolster job-creation in emerging markets, and support US foreign policy. The BUILD Act which created the DFC was a bipartisan bill, carefully craf...
Blog Post
June 04, 2021
Since March of 2020, COVID-19 changed most aspects of life as we knew it, from our personal day-to-day activities to the systems, processes, and structures that keep the global economy interconnected and moving. This included pharmaceutical production and distribution, where anecdotal evidence ...